Search For "selution slr"
Cordis Unveiled Positive Results for Two SELUTION SLR DEB Trials
Updated : 4 months, 2 weeks ago IST
Mumbai (Maharashtra) [India], November 11: Cordis, a global leader in interventional cardiovascular technology, announced the groundbreaking results from the SELUTION DeNovo and SELUTION4ISR trials at Transcatheter Cardiovascular Therapeutics® (TCT®) 2025, the annual scientific symposium of
Read More
MedAlliance Announces Enrollment of over 1,660 Patients in Landmark SELUTI
Updated : 2 years, 6 months ago IST
Geneva [Switzerland], September 15: MedAlliance has announced enrollment of over 1,660 patients in its ground-breaking SELUTION DeNovo coronary randomized study. Recruitment is now half way towards a planned 3,326 patients. SELUTION DeNovo compares the treatment strategy using a novel siroli
Read More
MedAlliance announces enrollment of First Patient in SELUTION SLR LOVE-DEB
Updated : 2 years, 6 months ago IST
Geneva [Switzerland], September 6: The first patient has been enrolled in a UK study of large vessel de novo coronary artery disease treated with SELUTION SLR™. This is a trial initiated by physicians at the Wrightington, Wigan and Leigh Teaching Hospitals NHS Foundation Trust, which i
Read More
Excellent 12-month results from SELUTION SFA trial presented at JET
Updated : 2 years, 9 months ago IST
Geneva [Switzerland], May 31: 12-month results from the SELUTION SFA trial have been presented at the Japan Endovascular Treatment (JET) Conference in Tokyo. The objective of this study was to assess the safety and efficacy of SELUTION SLR™, MedAlliance's novel sirolimus-eluting balloo
Read More
MedAlliance enrolls first US patient into its third FDA IDE Study: SFA SEL
Updated : 2 years, 10 months ago IST
Geneva [Switzerland], May 5 (ANI/PRNewswire): The first US patient has been enrolled in the SELUTION4SFA Sirolimus DEB study by Dr Arthur Lee at the Cardiac & Vascular Institute in Florida. This study evaluates SELUTION SLR™ in the treatment of occlusive disease of the superficial
Read More
MedAlliance leads US Sirolimus DEB race: First US Patient enrolled into SE
Updated : 3 years, 1 month ago IST
Geneva [Switzerland], January 26 (ANI/PRNewswire): The first US patient has been enrolled at MedStar Washington Hospital Center in the SELUTION4ISR study evaluating SELUTION SLR™ to support FDA approval. This milestone follows Investigational Device Exemption (IDE) approval in the US i
Read More
MedAlliance SELUTION SLR is the first DEB to receive coronary de novo IDE
Updated : 3 years, 2 months ago IST
Geneva [Switzerland], January 11 (ANI/PRNewswire): SELUTION SLR™, MedAlliance's novel sirolimus-eluting balloon, has received conditional FDA Investigational Device Exemption (IDE) approval to initiate its pivotal clinical trial for the treatment of coronary de novo lesions.
Read More
First patient enrolled in Erectile Dysfunction prospective randomized stud
Updated : 3 years, 6 months ago IST
Geneva [Switzerland], September 10 (ANI/PRNewswire): An 82-year-old Taiwanese man has become the first patient to be enrolled in the initial Erectile Dysfunction (ED) randomized clinical trial (RCT) involving SELUTION SLR™, MedAlliance's novel sirolimus-eluting balloon.
Read More
First US patient enrolled in SELUTION SLR IDE Peripheral Study
Updated : 3 years, 7 months ago IST
Geneva [Switzerland], August 24 (ANI/PRNewswire): The first US patient has been enrolled in the FDA SELUTION4BTK (Below-the-Knee) clinical trial evaluating SELUTION SLR™, MedAlliance's novel sirolimus-eluting balloon. This milestone follows Investigational Device Exemption (IDE) approv
Read More
MedAlliance SELUTION SLR receives second FDA IDE approval
Updated : 3 years, 7 months ago IST
Geneva [Switzerland], August 10 (ANI/PRNewswire): SELUTION SLR™, MedAlliance's novel sirolimus-eluting balloon, has received conditional FDA Investigational Device Exemption (IDE) approval to initiate its pivotal clinical trial for the treatment of occlusive disease of the superficial
Read More
First patient enrolled in SELUTION SLR IDE BTK Study
Updated : 3 years, 9 months ago IST
Leipzig [Germany], June 8 (ANI/PRNewswire): The first patient has been enrolled in the FDA IDE BTK (Below-the-Knee) SELUTION4BTK clinical trial involving SELUTION SLR™, MedAlliance's novel sirolimus-eluting balloon, just one week after receiving IDE approval.
Read More
18-Month Below-the-Knee data with MedAlliance's SELUTION SLR™ presen
Updated : 4 years, 5 months ago IST
Geneva [Switzerland], October 11 (ANI/PRNewswire): 18-month results from the PRESTIGE* Below-the-Knee (BTK) study have been presented as a Late Breaking Clinical Trial at VIVA21.
Read More